scispace - formally typeset
L

Ludovic Vallier

Researcher at University of Cambridge

Publications -  199
Citations -  17332

Ludovic Vallier is an academic researcher from University of Cambridge. The author has contributed to research in topics: Induced pluripotent stem cell & Embryonic stem cell. The author has an hindex of 55, co-authored 180 publications receiving 14503 citations. Previous affiliations of Ludovic Vallier include Wellcome Trust & Columbia University.

Papers
More filters
Journal ArticleDOI

Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development

TL;DR: A robust and efficient method to differentiate pluripotent stem cells into hepatic cells, which exhibit characteristics of human hepatocytes are reported, which should facilitate the development of clinical grade hepatocytes for transplantation and for research on drug discovery.
Journal ArticleDOI

The Cell-Cycle State of Stem Cells Determines Cell Fate Propensity

TL;DR: Using the FUCCI reporter system in human pluripotent stem cells is used to demonstrate that cell fate decisions are tightly associated with the cell-cycle machinery and reveal insights in the mechanisms synchronizing differentiation and proliferation in developing tissues.
Journal ArticleDOI

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression

TL;DR: It is demonstrated that Activin/Nodal signalling controls expression of the key pluripotency factor Nanog in human ESCs and in mouse EpiSCs, which prevents neuroectoderm differentiation induced by FGF signalling and limits the transcriptional activity of the Smad2/3 cascade, blocking progression along the endoderm lineage.
Journal ArticleDOI

Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway

TL;DR: Analysis of the Nodal-expressing phenotype suggests a function for the transforming growth factor-beta (TGF-beta) growth factor superfamily in pluripotency and in early cell fate decisions leading to primary tissue layers during in vitro development of pluripotent human stem cells.